TGF-β Pathways Stratify Colorectal Cancer into Two Subtypes with Distinct Cartilage Oligomeric Matrix Protein (COMP)

Jia-Tong Ding1,2, Hao-Nan Zhou1,3, Ying-Feng Huang1

  • 1Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.

Biomolecules
|December 23, 2022
PubMed
Summary

Cartilage oligomeric matrix protein (COMP) is a key gene for predicting colorectal cancer (CRC) subtypes. This finding offers new avenues for TGFβ-targeted therapies and clinical decision-making in CRC patients.